Research Project
Project Title: |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy (APPEAR) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy. |
Lead principal investigator(s): |
, |
Co-investigator(s): |
Erica Daina, Bergamo |
Project Period: |
07/2021 - 08/2023 |
« Back to research page